Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Applications for r-DNA derived Drugs via Sugam Portal: CDSCO

      Applications for r-DNA derived Drugs via Sugam Portal: CDSCO

      Ruby Khatun Khatun21 Jan 2018 9:15 AM IST
      Through a recent notification, CDSCO has said that the filling of application for Clinical Trial, Marketing Authorization, Registration Certificate...
      Health Budget to increase by 11 percent but Nadda stands disspointed

      Health Budget to increase by 11 percent but Nadda stands disspointed

      Ruby Khatun Khatun20 Jan 2018 4:27 PM IST
      New Delhi: India is poised to raise its public health spending by 11 percent in the annual budget next month, after rejecting the health minister's...
      Lupin launches generic version of Pfizers antibiotic in the US

      Lupin launches generic version of Pfizer's antibiotic in the US

      Ruby Khatun Khatun20 Jan 2018 11:44 AM IST
      New Delhi: Pharma major Lupin said it has launched Doxycycline Hyclate Tablet USP, 100 mg in the US market, used for the treatment of infections and...
      Health insurance should be made mandatory: NATHEALTH

      Health insurance should be made mandatory: NATHEALTH

      Ruby Khatun Khatun20 Jan 2018 11:30 AM IST
      New Delhi: The government should make health insurance mandatory for all citizens and give healthcare priority sector status, the Healthcare...
      Novartis gets US priority review for Kymriah for adults with lymphoma

      Novartis gets US priority review for Kymriah for adults with lymphoma

      Ruby Khatun Khatun20 Jan 2018 10:30 AM IST
      ZURICH: Novartis has been ‍granted the priority review for its cell therapy Kymriah for adults with a form of lymphoma by the U.S. Food and Drug...
      ADB invests 50 million dollars in True North to support mid-market businesses

      ADB invests 50 million dollars in True North to support mid-market businesses

      Ruby Khatun Khatun20 Jan 2018 10:00 AM IST
      New Delhi: The ADB said it has invested USD 50 million in True North VI LLP (True North VI) to provide equity capital to middle-market companies in...
      Erythromycin Price Fixation: NPPA Sets aside notification

      Erythromycin Price Fixation: NPPA Sets aside notification

      Ruby Khatun Khatun19 Jan 2018 3:39 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Suven gets product patents in China, Sri Lanka

      Suven gets product patents in China, Sri Lanka

      Ruby Khatun Khatun19 Jan 2018 11:00 AM IST
      New Delhi: Suven Life Sciences has secured a product patent each from China and Sri Lanka corresponding to the new chemical entities (NCEs) for the...
      Ipca Laboratories buys US API developer Pisgah Labs for 9.65 million dollars

      Ipca Laboratories buys US API developer Pisgah Labs for 9.65 million dollars

      Ruby Khatun Khatun19 Jan 2018 10:45 AM IST
      New Delhi: Ipca Laboratories Ltd said that its two subsidiaries have fully acquired US-based Pisgah Labs Inc. for $9.65 million.In a BSE filing, Ipca...
      Biocon collaborates with Sandoz for next-generation biosimilars

      Biocon collaborates with Sandoz for next-generation biosimilars

      Ruby Khatun Khatun19 Jan 2018 10:30 AM IST
      New Delhi: Bio-pharmaceuticals firm Biocon announced a global partnership with Sandoz, a Novartis division, to develop, manufacture and commercialize...
      Samsung inaugurates Smart Healthcare Program in Manipur, Madhya Pradesh

      Samsung inaugurates Smart Healthcare Program in Manipur, Madhya Pradesh

      Ruby Khatun Khatun19 Jan 2018 10:30 AM IST
      Imphal/Bhopal: Samsung India inaugurated the Samsung Smart Healthcare Program at Regional Institute of Medical Sciences (RIMS) in Imphal, Manipur and...
      Sanjay Dalmia makes foray into medical tourism

      Sanjay Dalmia makes foray into medical tourism

      Ruby Khatun Khatun19 Jan 2018 10:15 AM IST
      New Delhi: Dalmia Healthcare, the medical division of ace Industrialist Sanjay Dalmia has forayed into Medical Tourism. As a part of this venture, the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok